$1.33
0.043.10%
In chiusura: -
$1.33
0.000.00%
After hour: Oct 3, 5:08 PM EDT
Comments
Loading...
Report sulle vendite allo scoperto
Il short interest su Allogene Therapeutics Inc (NASDAQ:ALLO) è aumentato durante l'ultimo periodo di rilevazione, aumentando da 19.94M a 20.29M. Questo rappresenta il 11.04% delle azioni disponibili pubblicamente dell'azienda.
L'interesse allo scoperto in Allogene Therapeutics Corp (XNAS:ALLO) è diminuito durante l'ultimo periodo di rendicontazione, passando da 280,30 milioni a 275,20 milioni. Ciò ha portato allo scoperto l'1,17% delle azioni pubbliche della società.
Sulla base del volume medio recente di 2.14M azioni scambiate al giorno, ci vorrebbero 9.49 giorno(i) per chiudere le posizioni di questo interesse a breve senza spingere fortemente al rialzo il titolo.
Vendite allo scoperto
20.29M
Vendite allo scoperto %
11.0%
Giorni di copertura
9.49
Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|
ALLO | Allogene Therapeutics, Inc. Co | 09/15/2025 | 09/24/2025 | 11.04% | 183,805,037 | 20,285,441 | 2,137,986 | 9.49 | |
ALLO | Allogene Therapeutics, Inc. Co | 08/29/2025 | 09/10/2025 | 10.85% | 183,805,037 | 19,943,094 | 3,797,625 | 5.25 | |
ALLO | Allogene Therapeutics, Inc. Co | 08/15/2025 | 08/26/2025 | 13.31% | 183,805,037 | 24,472,217 | 7,011,325 | 3.49 | |
ALLO | Allogene Therapeutics, Inc. Co | 07/31/2025 | 08/11/2025 | 13.54% | 180,654,817 | 24,454,034 | 3,901,958 | 6.27 | |
ALLO | Allogene Therapeutics, Inc. Co | 07/15/2025 | 07/24/2025 | 14.35% | 180,654,817 | 25,930,643 | 3,818,488 | 6.79 | |
ALLO | Allogene Therapeutics, Inc. Co | 06/30/2025 | 07/10/2025 | 14.71% | 180,654,817 | 26,572,188 | 2,558,644 | 10.39 | |
ALLO | Allogene Therapeutics, Inc. Co | 06/13/2025 | 06/25/2025 | 14.42% | 180,654,817 | 26,041,918 | 2,703,576 | 9.63 | |
ALLO | Allogene Therapeutics, Inc. Co | 05/30/2025 | 06/10/2025 | 13.60% | 180,654,817 | 24,567,671 | 2,362,601 | 10.4 | |
ALLO | Allogene Therapeutics, Inc. Co | 05/15/2025 | 05/27/2025 | 15.15% | 180,654,817 | 27,361,306 | 5,324,896 | 5.14 | |
ALLO | Allogene Therapeutics, Inc. Co | 04/30/2025 | 05/09/2025 | 19.22% | 156,710,201 | 30,125,461 | 2,247,050 | 13.41 | |
ALLO | Allogene Therapeutics, Inc. Co | 04/15/2025 | 04/25/2025 | 20.94% | 156,710,201 | 32,811,049 | 3,167,452 | 10.36 | |
ALLO | Allogene Therapeutics, Inc. Co | 03/31/2025 | 04/09/2025 | 22.18% | 156,710,201 | 34,756,318 | 3,514,828 | 9.89 | |
ALLO | Allogene Therapeutics, Inc. Co | 03/14/2025 | 03/25/2025 | 24.26% | 156,710,201 | 38,012,142 | 3,259,936 | 11.66 | |
ALLO | Allogene Therapeutics, Inc. Co | 02/28/2025 | 03/11/2025 | 26.22% | 149,117,554 | 39,095,990 | 14,864,570 | 2.63 | |
ALLO | Allogene Therapeutics, Inc. Co | 02/14/2025 | 02/26/2025 | 22.57% | 149,117,554 | 33,662,897 | 6,638,865 | 5.07 | |
ALLO | Allogene Therapeutics, Inc. Co | 01/31/2025 | 02/11/2025 | 21.49% | 149,117,554 | 32,048,327 | 2,305,377 | 13.9 | |
ALLO | Allogene Therapeutics, Inc. Co | 01/15/2025 | 01/27/2025 | 21.70% | 149,117,554 | 32,352,285 | 3,269,259 | 9.9 | |
ALLO | Allogene Therapeutics, Inc. Co | 12/31/2024 | 01/10/2025 | 20.73% | 149,117,554 | 30,906,822 | 2,890,694 | 10.69 | |
ALLO | Allogene Therapeutics, Inc. Co | 12/13/2024 | 12/24/2024 | 21.71% | 149,117,554 | 32,371,979 | 2,335,231 | 13.86 | |
ALLO | Allogene Therapeutics, Inc. Co | 11/29/2024 | 12/10/2024 | 20.90% | 149,117,554 | 31,167,763 | 2,703,155 | 11.53 | |
ALLO | Allogene Therapeutics, Inc. Co | 11/15/2024 | 11/26/2024 | 23.50% | 149,117,554 | 35,047,242 | 2,722,218 | 12.87 | |
ALLO | Allogene Therapeutics, Inc. Co | 10/31/2024 | 11/11/2024 | 24.84% | 149,117,554 | 37,040,821 | 1,953,521 | 18.96 | |
ALLO | Allogene Therapeutics, Inc. Co | 10/15/2024 | 10/24/2024 | 26.47% | 148,556,979 | 39,318,504 | 1,705,003 | 23.06 | |
ALLO | Allogene Therapeutics, Inc. Co | 09/30/2024 | 10/09/2024 | 25.92% | 148,556,979 | 38,512,665 | 2,170,473 | 17.74 | |
ALLO | Allogene Therapeutics, Inc. Co | 09/13/2024 | 09/24/2024 | 26.38% | 148,556,979 | 39,187,976 | 1,742,881 | 22.48 | |
ALLO | Allogene Therapeutics, Inc. Co | 08/30/2024 | 09/11/2024 | 26.21% | 148,556,979 | 38,940,757 | 1,695,830 | 22.96 | |
ALLO | Allogene Therapeutics, Inc. Co | 08/15/2024 | 08/26/2024 | 26.41% | 148,556,979 | 39,229,292 | 1,762,681 | 22.26 | |
ALLO | Allogene Therapeutics, Inc. Co | 07/31/2024 | 08/09/2024 | 25.41% | 148,556,979 | 37,750,648 | 2,757,295 | 13.69 | |
ALLO | Allogene Therapeutics, Inc. Co | 07/15/2024 | 07/24/2024 | 29.16% | 148,229,877 | 43,225,799 | 2,382,360 | 18.14 | |
ALLO | Allogene Therapeutics, Inc. Co | 06/28/2024 | 07/10/2024 | 27.92% | 148,229,877 | 41,384,695 | 4,275,506 | 9.68 | |
ALLO | Allogene Therapeutics, Inc. Co | 06/14/2024 | 06/26/2024 | 29.20% | 148,229,877 | 43,277,309 | 2,594,733 | 16.68 | |
ALLO | Allogene Therapeutics, Inc. Co | 05/31/2024 | 06/11/2024 | 27.37% | 148,229,877 | 40,567,051 | 3,207,724 | 12.65 | |
ALLO | Allogene Therapeutics, Inc. Co | 05/15/2024 | 05/24/2024 | 24.58% | 148,229,877 | 36,428,594 | 2,167,686 | 16.81 | |
ALLO | Allogene Therapeutics, Inc. Co | 04/30/2024 | 05/09/2024 | 30.71% | 110,298,842 | 33,867,289 | 2,055,356 | 16.48 | |
ALLO | Allogene Therapeutics, Inc. Co | 04/15/2024 | 04/24/2024 | 28.47% | 110,168,563 | 31,360,608 | 1,632,502 | 19.21 | |
ALLO | Allogene Therapeutics, Inc. Co | 03/28/2024 | 04/09/2024 | 26.60% | 115,114,793 | 30,621,417 | 1,841,688 | 16.63 | |
ALLO | Allogene Therapeutics, Inc. Co | 03/15/2024 | 03/26/2024 | 24.11% | 115,114,793 | 27,749,018 | 3,336,219 | 8.32 | |
ALLO | Allogene Therapeutics, Inc. Co | 02/29/2024 | 03/11/2024 | 21.81% | 114,665,039 | 25,007,919 | 2,050,440 | 12.2 | |
ALLO | Allogene Therapeutics, Inc. Co | 02/15/2024 | 02/27/2024 | 20.51% | 114,299,463 | 23,447,504 | 2,568,749 | 9.13 | |
ALLO | Allogene Therapeutics, Inc. Co | 01/31/2024 | 02/09/2024 | 20.20% | 114,299,463 | 23,085,975 | 2,491,223 | 9.27 | |
ALLO | Allogene Therapeutics, Inc. Co | 01/12/2024 | 01/24/2024 | 26.43% | 114,299,463 | 30,205,958 | 4,202,446 | 7.19 | |
ALLO | Allogene Therapeutics, Inc. Co | 12/29/2023 | 01/10/2024 | 27.40% | 114,299,463 | 31,323,687 | 2,799,115 | 11.19 | |
ALLO | Allogene Therapeutics, Inc. Co | 12/15/2023 | 12/27/2023 | 29.36% | 114,299,463 | 33,553,816 | 4,021,844 | 8.34 | |
ALLO | Allogene Therapeutics, Inc. Co | 11/30/2023 | 12/11/2023 | 27.87% | 114,299,463 | 31,856,812 | 2,260,169 | 14.09 | |
ALLO | Allogene Therapeutics, Inc. Co | 11/15/2023 | 11/27/2023 | 28.30% | 114,299,463 | 32,343,375 | 2,593,793 | 12.47 | |
ALLO | Allogene Therapeutics, Inc. Co | 10/31/2023 | 11/09/2023 | 29.77% | 114,299,463 | 34,031,762 | 1,219,784 | 27.9 | |
ALLO | Allogene Therapeutics, Inc. Co | 10/13/2023 | 10/24/2023 | 27.04% | 113,649,166 | 30,729,965 | 1,308,808 | 23.48 | |
ALLO | Allogene Therapeutics, Inc. Co | 09/29/2023 | 10/10/2023 | 30.03% | 113,649,166 | 34,128,981 | 1,449,297 | 23.55 |
In cerca di azioni più vendute allo scoperto?